Prognostic factors for treatment response and survival outcomes after first-line management of Stage 4 non-small cell lung cancer: A real-world Indian perspective-Reference-Cited by-同舟云学术

Prognostic factors for treatment response and survival outcomes after first-line management of Stage 4 non-small cell lung cancer: A real-world Indian perspective

Published:2022 Issue:2 Volume:39 Page:102
ISSN:0970-2113
Container-title:Lung India
language:en
Short-container-title:Lung India

Author:

Mohan Anant,Garg Avneet,Iyer Hariharan,Jindal Vinita,Vashistha Vishal,Ali Ashraf,Jain Deepali,Tiwari Pawan,Mittal Saurabh,Madan Karan,Hadda Vijay,Guleria Randeep,Sati HemChandra

Publisher

Medknow

Subject

Pulmonary and Respiratory Medicine

Reference35 articles.

1. Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center;Mohan;Lung India,2020

2. Outcomes in lung cancer: 9-year experience from a tertiary cancer center in India;Murali;J Glob Oncol,2017

3. Factors affecting 30-month survival in lung cancer patients;Mahesh;Indian J Med Res,2012

4. Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India;Julka;J Egypt Natl Canc Inst,2017

5. Pattern and determinants of survival among lung cancer patients in Western part of India;Dixit;Chest,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival among patients with lung cancer managed at a tertiary care center in North India;Monaldi Archives for Chest Disease;2024-07-26

2. Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase– and ROS1 Fusion–Positive Non–Small Cell Lung Cancer in India;JCO Global Oncology;2024-02

3. Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer;Frontiers in Oncology;2023-02-16

4. Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya;Cancer Medicine;2023-01-27

5. A combined iterative sure independence screening and Cox proportional hazard model for extracting and analyzing prognostic biomarkers of adenocarcinoma lung cancer;Healthcare Analytics;2022-11